During the past decade, Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 35 clinical trials were completed, i.e. on average, 67.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 19 clinical trials were completed. i.e. 105.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Celgene" with 6 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Shire" with 5 trials sponsored and "Takeda" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" #1 collaborator was "Department of Health and Human Services" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Akcea Therapeutics" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" are "Ulcerative Colitis" (8 trials), "Crohn Disease" (6 trials), "Crohn's Disease" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials) and "Arthritis, Psoriatic" (3 trials). Many other conditions were trialed in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" in a lesser frequency.

Most popular intervention types in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" are "Drug" (72 trials), "Other" (12 trials), "Biological" (9 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Ontamalimab" (4 trials), "Bevacizumab" (3 trials), "Etrolizumab" (3 trials) and "K-877" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" are 78 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz". undefined are not yet recruiting, 12 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz has several departments that took part in Clinical trials: "Fejér Megyei Szent György Kórház; Onkológiai Osztály" - 2 trials